Bay Harbor Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$790 Buy
10
+4
+67% +$340 ﹤0.01% 946
2026
Q1
$516 Buy
6
+4
+200% +$359 ﹤0.01% 986
2025
Q4
$174 Buy
2
+1
+100% +$76 ﹤0.01% 1138
2025
Q3
$57 Buy
+1
New +$58 ﹤0.01% 1230

Other funds holding GMED

Bay Harbor Wealth Management's GMED Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Globus Medical (GMED) stake by 67% in Q2 2026, buying an estimated $340 and bringing the position to 10 shares worth $790. The position accounts for ﹤0.01% of the portfolio, ranked #946.

Bay Harbor Wealth Management first reported a position in GMED in Q3 2025 and has held it in 4 quarters since. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Bay Harbor Wealth Management held 10 shares of Globus Medical worth $790 as of Q2 2026.
  • Bay Harbor Wealth Management bought 4 Globus Medical shares in Q2 2026, an estimated $340.
  • Globus Medical made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #946 holding.
  • Bay Harbor Wealth Management first reported a position in Globus Medical in Q3 2025 and has held it in 4 quarters since.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.